Tracking the assembly pathway of human immunodeficiency virus type 1 Gag deletion mutants by immunogold labeling

Applied Immunohistochemistry and Molecular Morphology

Volumn 9, Issue 4, 2001, Pages 371-379

  Wang, J J ^a   Sandefur, S ^a   Spearman, P ^a   Chiou, C T ^a   Chiang, P H ^a   Ratner, L ^a  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

Assembly; Gag protein; Human immunodeficiency virus type 1

Indexed keywords

GAG PROTEIN; MUTANT PROTEIN; VIRUS PROTEIN; HIV 1 GAG PRECURSOR P55; HIV-1 GAG PRECURSOR P55; PROTEIN PRECURSOR;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL SURFACE; CELLULAR DISTRIBUTION; CYTOPLASM; DELETION MUTANT; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOELECTRON MICROSCOPY; IMMUNOGOLD STAINING; MEMBRANE VESICLE; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; MORPHOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ASSEMBLY; PROTEIN LOCALIZATION; ROUGH ENDOPLASMIC RETICULUM; VIRUS NUCLEOCAPSID; BIOSYNTHESIS; CELL CULTURE; CELL STRUCTURE; ELECTRON MICROSCOPY; GENE DELETION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; IMMUNOHISTOCHEMISTRY; LEUKEMIA CELL LINE; METABOLISM; VIRION; VIRUS REPLICATION;

CELLULAR STRUCTURES; GENE PRODUCTS, GAG; HUMAN; IMMUNOHISTOCHEMISTRY; JURKAT CELLS; MICROSCOPY, ELECTRON; NUCLEOCAPSID; PROTEIN PRECURSORS; SEQUENCE DELETION; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR CELLS, CULTURED; VIRION; VIRUS REPLICATION;

EID: 0035200731     PISSN: 10623345     EISSN: None     Source Type: Journal    
DOI: 10.1097/00022744-200112000-00014     Document Type: Article

References (60)

1. The C-terminal half of the human immunodeficiency virus type 1 Gag precursor is sufficient for efficient particle assembly
2. Macromolecular interactions in the assembly of HIV and other retroviruses
3. Analysis of protein expression and virus-like particle formation in mammalian cell lines stably expressing HIV-1 gag and env gene products with or without active HIV proteinase
4. Intracellular transport of retroviral capsid components
5. gag and Pr160gag-pol expressed from a simian virus 40 late replacement vector are efficiently processed and assembled into viruslike particles
6. Efficient particle production by minimal gag constructs which retain the carboxy-terminal domain of human immunodeficiency virus type 1 capsid-p2 and a late assembly domain
7. Human immunodeficiency virus type 1 MA deletion mutants expressed in baculovirus-infected cells: Cis and trans effects on the Gag precursor assembly pathway
8. Morphopoietic determinants of HIV-1 gag particles assembled in baculovirus-infected cells
9. A conformational switch controlling HIV-1 morphogenesis
10. Myristylation-dependent replication and assembly of human immunodeficiency virus 1
11. Single amino acid changes in the human immunodeficiency virus type 1 matrix protein block virus particle production
12. HIV-1 gag proteins: Diverse functions in the virus life cycle
13. Reversion of a human immunodeficiency virus type 1 matrix mutation affecting Gag membrane binding, endogenous reverse transcriptase activity, and virus infectivity
14. In vitro assembly of human immunodeficiency virus type 1 Gag protein
15. Roles of matrix, p2, and N-terminal myristylation in human immunodeficiency virus type 1 Gag assembly
16. Role of gag matrix in targeting human immunodeficiency virus type 1 assembly
17. Analysis of minimal human immunodeficiency virus type 1 gag coding sequences capable of virus-like particle assembly and release
18. Assembly and processing of human immunodeficiency virus Gag mutants containing a partial replacement of the matrix domain by the viral protease domain
19. Molecular determinants of acute singe cell lysis by human immunodeficiency virus type 1
20. Mapping and characterization of the N-terminal I domain of human immunodeficiency virus type 1 Pr55 Gag
21. Gag exert a cell type-dependent effect on viral replication and virion incorporation of Pol proteins
22. Particle size determinants in the human immunodeficiency virus type 1 gag protein
23. Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease
24. A leucine-triplet repeat sequence in Gag p6 required for HIV-1 Vpr particle incorporation
25. Localization of human immunodeficiency virus type 1 Gag and Env at the plasma membrane by Confocal imaging
26. Binding of human immunodeficiency virus type 1 Gag to membrane: Role of the matrix amino terminus
27. Viral interactions with the host cell cytoskeleton: The role of retroviral proteases
28. Role of the cytoskeleton in cell-to-cell transmission of human immunodeficiency virus
29. Tagging the human immunodeficiency virus gag protein with green fluorescent protein minimal evidence for colocalisation with actin
30. Effects of brefeldin A on the Golgi complex, endoplasmic reticulum and viral envelope glycoproteins in murine erythroleukemia cells
31. Assembly and composition of intracellular particles formed by Moloney murine leukemia virus
32. Membrane binding of human immunodeficiency virus type 1 matrix protein in vivo supports a conformational myristyl switch mechanism
33. Efficient HIV-1 replication can occur in the absence of the viral matrix protein
34. A large deletion in matrix domain of the human immunodeficiency virus gag gene redirects virus particle assembly from the plasma membrane to the endoplaslmic reticulum
35. Influence of MA internal sequences, but not of the myristylated N-terminus sequence, on the binding site of HIV-1 Gag protein
36. Identification of HIV-1 gag protein domains essential to membrane binding and particle assembly
37. Two nuclear localization signals in the HIV-1 matrix protein regulate nuclear import of the HIV-1 pre-integration complex
38. A novel nuclear export activity in HIV-1 matrix protein required for viral replication
39. Formation and release of virus-like particles by HIV-1 matrix protein
40. Dynamic interactions of the gag polyprotein
41. Formation of virus assembly intermediate complexes in the cytoplasm by wild-type and assembly-defective mutant human immunodeficiency virus type 1 and their association with membranes
42. Functional domains of HIV-1 gag-polyprotein expressed in baculovirus-infected cells
43. Opposing effects of human immuno-deficiency virus type 1 matrix mutations support a myristal switch model of Gag membrane targeting
44. A cell-line-specific defect in the intracellular transport and release of assembled retroviral capsids
45. Kinetic analysis of human immunodeficiency virus type 1 assembly reveals the presence of sequential intermediates
46. The I domain is required for efficient plasma membrane binding of human immunodeficiency virus type 1 Pr55gag
47. Particle assembly and Vpr expression in human immunodeficiency virus type 1-infected cells demonstrated by immunoelectron microscopy
48. Human immunodeficiency virus replication in a primary effusion lymphoma cell line stimulates lytic-phase replication of Kaposi's sarcoma-associated herpesvirus
49. Self-assembly in vitro of purified CA-NC proteins from Rous sarcoma virus and human immunodeficiency virus type 1
50. In vitro assembly properties of human immunodeficiency virus type 1 gag protein lacking the p6 domain
51. HIV Type 2 Vpx interaction with Gag and incorporation into virus-like articles
52. Comparative morphology of Gag protein structures produced by mutants of the gag gene of human immunodeficiency virus type 1
53. Molecular modelling study of HIV p17gag (MA) protein shell utilising data from electron microscopy and x-ray cry stallography
54. Intracellular interaction of simian immunodeficiency virus Gag and Env proteins
55. Genetic evidence for an interaction between human immunodeficiency virus type 1 matrix and a-helix 2 of the gp41 cytoplasmic tail
56. Presence of HIV-1 in the sperm of patients with HIV/AIDS
57. Detection of HIV-1 proviral DNA in sperm from HIV-1-infected men
58. Apoptosis control in syncytia induced by the HIV type 1-envelope glycoprotein complex. Role of mitochondria and caspases
59. Mitochondrial targeting of the p13II protein coded by the x-II ORF of human T-cell leukemia/lymphotropic virus type I (HTLV-I)
60. The p13II protein of HTLV type I: Comparison with mitochondrial proteins coded by other human viruses